Search research articles
Contact Us
Filters
Showing results (1-10 of 143) with videos related to
Page
of 15
Sort By:
Hepatology, Medicine and Policy
|
October 6, 2018
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Soo Aleman
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 29, 2022
Natural history of untreated HDV patients: Always a progressive disease?
Habiba Kamal, Soo Aleman,
Archivum Immunologiae Et Therapiae Experimentalis
|
August 20, 2013
Functional attributes of responding T cells in HCV infection: the recent advances in engineering functional antiviral T cells
Anna Pasetto, Soo Aleman, Margaret Chen
Lakartidningen
|
June 3, 2009
[Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C]
Johan Björklund, Soo Aleman, Ola Weiland
Lakartidningen
|
April 9, 2020
Hedvig Glans, Anders Sönnerborg, Soo Aleman
Hepatology (Baltimore, Md.)
|
August 9, 2020
REPLY
Habiba Kamal, Ola Weiland, Soo Aleman
AIDS (London, England)
|
January 27, 2022
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
Xinling Xu, Jan Vesterbacka, Soo Aleman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2016
Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C
Magnus Hedenstierna, Ali Nangarhari, Ola Weiland, et al.
BMC Psychiatry
|
March 28, 2025
Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of care
Per-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
AIDS (London, England)
|
April 13, 2004
Minor nef gene alterations after human HIV-DNA immunisation
Soo Aleman, Thomas Leitner, Margaret A Liu, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 143) with videos related to
Sort By:
Page
of 15
Hepatology, Medicine and Policy
|
October 6, 2018
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure
Soo Aleman
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 29, 2022
Natural history of untreated HDV patients: Always a progressive disease?
Habiba Kamal, Soo Aleman,
Archivum Immunologiae Et Therapiae Experimentalis
|
August 20, 2013
Functional attributes of responding T cells in HCV infection: the recent advances in engineering functional antiviral T cells
Anna Pasetto, Soo Aleman, Margaret Chen
Lakartidningen
|
June 3, 2009
[Fibrosis indexes reduce the need of liver biopsy in chronic hepatitis C]
Johan Björklund, Soo Aleman, Ola Weiland
Lakartidningen
|
April 9, 2020
Hedvig Glans, Anders Sönnerborg, Soo Aleman
Hepatology (Baltimore, Md.)
|
August 9, 2020
REPLY
Habiba Kamal, Ola Weiland, Soo Aleman
AIDS (London, England)
|
January 27, 2022
High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
Xinling Xu, Jan Vesterbacka, Soo Aleman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2016
Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C
Magnus Hedenstierna, Ali Nangarhari, Ola Weiland, et al.
BMC Psychiatry
|
March 28, 2025
Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of care
Per-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
AIDS (London, England)
|
April 13, 2004
Minor nef gene alterations after human HIV-DNA immunisation
Soo Aleman, Thomas Leitner, Margaret A Liu, et al.
Page
of 15